Decreasing vascular complications after percutaneous coronary interventions: Partnering to improve outcomes

Critical Care Nurse

Volumn 26, Issue 6, 2006, Pages 38-45

  Lins, Sandra ^a   Guffey, Denise ^a,b   VanRiper, Sharon ^c   Kline Rogers, Eva ^c  

^a OAKWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^b Southshore Hospital in Trenton   (United States)

^c UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ARTERIOVENOUS FISTULA; BLOOD CLOTTING TIME; CASE REPORT; CLINICAL COMPETENCE; DRUG MONITORING; EDUCATION; FALSE ANEURYSM; FEMALE; HEALTH SERVICE; HEMATOMA; HUMAN; METHODOLOGY; MIDDLE AGED; NURSING; NURSING STAFF; ORGANIZATION AND MANAGEMENT; POSTOPERATIVE CARE; PUBLIC RELATIONS; QUALITY CONTROL; REVIEW; RISK FACTOR; STANDARD; TOTAL QUALITY MANAGEMENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNITED STATES; VASCULAR DISEASE;

ANEURYSM, FALSE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ARTERIOVENOUS FISTULA; BENCHMARKING; CLINICAL COMPETENCE; DRUG MONITORING; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HEMATOMA; HUMANS; INTERINSTITUTIONAL RELATIONS; MICHIGAN; MIDDLE AGED; NURSING STAFF, HOSPITAL; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POSTOPERATIVE CARE; RISK FACTORS; TOTAL QUALITY MANAGEMENT; VASCULAR DISEASES; WHOLE BLOOD COAGULATION TIME;

EID: 39049185161     PISSN: 02795442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Muller M. Arterial puncture closing devices compared to standardized manual compression after cardiac catheterization: a systemic review and meta-analysis. JAMA. 2004;291:350-357.
2. Piper W, Malenka D, Ryan T, et al. Predicting vascular complications in percutaneous coronary interventions. Am Heart J. 2003;145:1022-1029.
3. Davis C, VanRiper S, Longstreet J, Moscucci M. Vascular complications of coronary interventions. Heart Lung. 1997;26:118-127.
4. Popma JJ, Satler FL, Richard AD, et al. Vascular complications after balloon and new device angioplasty. Circulation. 1993;88: 1569-578.
5. Moscucci M, Ricciardi M, Eagle KA, et al. Frequency, predictors, and appropriateness of blood transfusion after percutaneous coronary interventions. Am J Cardiol. 1998;81:702-707.
6. Blankenship J, Hellkamp A, Aguirre F, et al. Vascular access site complications after percutaneous coronary intervention with abciximab in the evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial. Am J Cardiol. 1998;81:36-40.
7. Moscucci M, Mansour KA, Kent KC, et al. Peripheral vascular complications of directional coronary atherectomy and stenting: predictors, management, and outcome. Am J Cardiol. 1994; 74:448-453.
8. Nikolsky E, Mehran R, Halkin A, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44:1200-1209.
9. Farouque H, Tremmel J, Raissi Shabari F, et al. Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol. 2005;45:363-368.
10. Moscucci M, Share D, Kline-Rogers E, et al. The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions. J Intervent Cardiol. 2002;15:381-386.
11. Kline-Rogers E, Share D, Bondie D, et al. Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). J Intervent Cardiol. 2002;15:387-392.
12. Turi Z. Closure device overview. Endovasc Today. April 2003:40-46.
13. Silber S. Vascular closure devices for immediate sheath removal after coronary interventions: luxury or necessity? In: Serruys P, Kutryk M, eds. Handbook of Coronary Stents. 3rd ed. London, England: Martin Dunitz Publishers Ltd; 2000:147-151.
14. Tolleson TR, O'Shea JC, Bittl JA, et al. Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT Trial. J Am Coll Cardiol. 2003;41:386-393.
15. Simko RJ, Tsung FF, Stanek EJ. Activated clotting time versus activated partial thromboplastin time for therapeutic monitoring of heparin. Ann Pharmacother. 1995;29: 1015-1021.
16. Balcezak TJ, Krumholz HM, Getnick GS, Vaccarino V, Lin ZQ, Cadman EC. Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center. Am J Manag Care. 2000; 6:329-338.
17. Zimmermann AT, Jeffries WS, McElroy H, Horowitz JD. Utility of a weight-based heparin nomogram for patients with acute coronary syndromes. Intern Med J. 2003; 33:18-25.
18. Ryan T, Antman E, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction - executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999; 100:1016-1030.